The subsequent drop in MDMA content in tablets since 2019 does not appear to have been accompanied by a significant drop in price. In 2021, adult respondents to the EWSD reported paying a median of EUR 7.20 per ecstasy tablet and a median of EUR 37.40 per gram for MDMA powder. (a) In clinical trials, doses of MDMA capable of producing subjective effects vary from 1.5 to 1.7 mg/kg of body weight, or approximately 105 to 119 milligrams for a 70-kilogram individual. Harm reduction responses, including the provision of drug-checking services and appropriate risk-communication strategies, are crucial to minimise these risks. Some tablets even contain stamping that indicate the quantity of MDMA present, although this is not always accurate and may also constitute a health risk. For example, in August 2023, tablets containing 350 milligrams of MDMA were seized in Spain.


While individual tablet weight cannot be a direct predictor of how much MDMA is present in each tablet, at population level this trend is consistent when comparing larger ecstasy tablets (almost always containing more MDMA) with smaller tablets (almost always containing less MDMA). This means that the ratio of MDMA to fillers (excipients) in the mixtures used to make ecstasy tablets did not increase over this time period. In the first period, between 2011 and 2019, the increase in MDMA content is largely attributed to the sale of larger (heavier) ecstasy tablets. This means that consumers buying ecstasy tablets in Europe in 2019 would obtain a product containing up to almost double the highest amount of MDMA recorded in ecstasy tablets in 2011. In Australia, in January 2024, potent opioids of the nitazene family were found in brightly coloured tablets with logos reminiscent of ecstasy tablet


Most MDMA-related hospital emergency cases involved males, confirming trends in prevalence and patterns of use. Half of the centres reported no MDMA-related admissions to the intensive care unit. Türkiye is an outlier, with MDMA identified in almost 1 in 5 drug-induced deaths (46 out of 246 in 2022). A minority of these fatalities (13-25 %) were due to MDMA toxicity alone, with multiple drug toxicity being more prevalen

Surrey Young People’s Substance Use Service
Contact your health-care provider immediately if you suspect that you have a medical problem. You should not use this information as self-diagnosis or for treating a health problem or disease. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. buy mdma Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Choosing 12 Panel Now provides customers with a comprehensive and cutting-edge solution for drug testing needs. Utilizing a MDMA Ecstasy/Molly Test is beneficial for employers and institutions aiming to maintain drug-free environments.


Perhaps most obviously it demonstrates, yet again, the futility of putting enforcement, targeting either people who use or supply, at the forefront of the policy response to drugs. The EMCDDA also reported in 2019 that ‘transactions involving quantities of MDMA tablets indicative of the middle level of the market account for more than double the revenue of sales of retail-level quantities’. Prevalence of drug use data tables including general population surveys and wastewater analysis (all substances) Alcohol was co-consumed across 67 % of all MDMA-related hospital emergencies, and the other drugs commonly consumed alongside MDMA included cocaine, amphetamine, methamphetamine, ketamine, heroin, GHB and cannabis. The share of acute drug-toxicity presentations involving MDMA increased as compared to other substances and the previous year (or MDMA was reported for the first time) in 10 of the Euro-DEN hospitals. The majority of drug-induced deaths in Türkiye are among younger people, predominantly males, and are more likely to involve stimulant drugs rather than buy mdma opioids, compared with the European Union and Norwa

Wastewater data also reflect the predominant use of ecstasy in recreational settings, with more than three quarters of cities reporting that higher loads of MDMA were present in wastewater during the weekend than during weekdays in 2022.

The share of acute drug-toxicity presentations involving MDMA increased as compared to other substances and the previous year (or MDMA was reported for the first time) in 10 of the Euro-DEN hospitals. When using wastewater data to estimate MDMA markets, the use of MDMA is based on the excreted parent drug, rather than on an excreted metabolite (which is the case for some other drugs, such as cocaine and heroin). Demand-based estimates may underestimate the size of drug markets for a number of reasons, including difficulty reaching some groups of users, and underreporting of prevalence and quantities used by respondents. Estimates of amounts used suggest that about 72.4 million ecstasy tablets were consumed in the European Union in 2021. The total quantity of MDMA consumed in Europe is reached by multiplying the number of users by the amount used, combining prevalence data from general population surveys and the amount used from the EWSD. Information gathered in the 2021 EWSD suggests that, on average, those who reported having used MDMA in the last 12 months, consumed one ecstasy tablet or 0.4 grams of MDMA in crystal or powders form each time they used the drug.
THC Drug Test – Marijuana Urine Dip Test 50 ng/ml